IsoPlexis Corp (ISO): Price and Financial Metrics
ISO Price/Volume Stats
|Current price||$0.76||52-week high||$5.10|
|Prev. close||$0.74||52-week low||$0.60|
|Day high||$0.79||Avg. volume||68,375|
|50-day MA||$1.15||Dividend yield||N/A|
|200-day MA||$1.81||Market Cap||30.28M|
ISO Stock Price Chart Interactive Chart >
IsoPlexis Corp (ISO) Company Bio
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations without the need for highly specialized informatics professionals, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.
ISO Latest News Stream
|Loading, please wait...|
ISO Latest Social Stream
View Full ISO Social Stream
Latest ISO News From Around the Web
Below are the latest news stories about ISOPLEXIS CORP that investors may wish to consider to help them evaluate ISO as an investment opportunity.
Q4 2022 Berkeley Lights Inc Earnings Call
IsoPlexis Corporation's (NASDAQ:ISO) recent US$6.3m market cap decline means a loss of US$65k for insiders who bought this year
The recent price decline of 11% in IsoPlexis Corporation's ( NASDAQ:ISO ) stock may have disappointed insiders who...
BRANFORD, Conn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary unaudited revenue for the full year ended December 31, 2022. Total revenue for the full year ended December 31, 2022 is expected to be in the range of $16.6 to $16.8 million, representing a decrease of approximately 3% to 4% compared to $17.3 million for the full year ended Decembe
Cenntro Electric (CENN) stock is on the move Thursday as investors react to the EPA granting a Certificate of Conformity to the company.
Under Armour (UA) stock is in the news after the company named Stephanie Linnartz as its new President, CEO, and board member.
ISO Price Returns